FACULTY
New Treatments for the Management of Treatment-Experienced Breast Cancer: Examining the Evidence
Including proceedings from a roundtable held in Scottsdale, Arizona.
Activity Date: December 2007  — Activity Info: Volume 4, (13)
Goals & Objectives | Faculty | Introduction | Full Activity Content | CME Test & Evaluation (CME Expired)

 

Full Disclosure Policy Affecting CE Activities:
As a sponsor accredited by the Accreditation Council for Pharmacy Education (ACPE), it is the policy of the University of Tennessee College of Pharmacy to require the disclosure of the existence of any significant financial interest or any other relationship a faculty member or a sponsor has with the manufacturer(s) of any commercial product(s) discussed in an educational presentation. The Program Director and Participating Faculty reported the following:

PROGRAM DIRECTOR

J. Aubrey Waddell, PharmD, FAPhA, BCOP
Associate Professor
University of Tennessee College of Pharmacy
Oncology Pharmacist
Blount Memorial Hospital
Maryville, Tennessee
Dr Waddell reports having no significant financial or advisory relationships with corporate organizations related to this activity.

PARTICIPATING FACULTY

Nelly G. Adel, PharmD, BCOP
Manager, Clinical Pharmacy Services
Oncology Residency Program Director
Memorial Sloan-Kettering Cancer Center
New York, New York
Dr Adel reports receiving honoraria from Amgen, Inc and AstraZeneca.

Virna Almuete, PharmD
Pharmacy Operations Manager
The Sidney Kimmel Comprehensive Cancer Center
The Johns Hopkins Hospital
Associate Clinical Professor
University of Maryland School of Pharmacy
Baltimore, Maryland
Dr Almuete reports having no significant financial or advisory relationships with corporate organizations related to this activity.

Robert J. Ignoffo, PharmD, FASHP, FCSHP
Emeritus Clinical Professor
University of California at San Francisco
San Francisco, California
Professor of Pharmacy
College of Pharmacy
Touro University California
Vallejo, California
Dr Ignoffo reports receiving grants/research support from and serving as a consultant for MGI Pharma; and receiving honoraria from Amgen, Inc, MGI Pharma, and Novartis.

John G. Kuhn, PharmD, FCCP, BCOP
Endowed Professor
University of Texas College of Pharmacy
Austin, Texas
University of Texas Health Science Center
Pharmacology Core Director
North American Brain Tumor Consortium
Medical Research Director
South Texas Oncology/Hematology
San Antonio, Texas
Dr Kuhn reports having no significant financial or advisory relationships with corporate organizations related to this activity.

Patrick J. Medina, PharmD, BCOP
Associate Professor
The University of Oklahoma College of Pharmacy
Oklahoma City, Oklahoma
Dr Medina reports having no significant financial or advisory relationships with corporate organizations related to this activity.

Dominic A. Solimando, Jr, MA, BCOP
President
Oncology Pharmacy Services, Inc.
Arlington, Virginia
Dr Solimando reports having no significant financial or advisory relationships with corporate organizations related to this activity.

William C. Zamboni, PharmD, PhD
Assistant Professor
University of Pittsburgh Cancer Institute
Pittsburgh, Pennsylvania
Dr Zamboni reports receiving grants/research support from Alza, GlaxoSmithKline, Hana, and Sanofi-Aventis; serving as a consultant for Alza, Amgen, Inc, Hana, Labopharm, and SuperGen; and receiving honoraria from Alnylam Pharmaceuticals, Mersana, and University Pharmacotherapy Associates, LLC.

Notice: In accordance with the ACPE Criteria for Quality, the audience is advised that an article in this CE activity may contain reference(s) to unlabeled or unapproved uses of drugs or devices.

Dr Adel–phase I, II, III trials of epothilones (ixabepilone [BMS-247550]).

All other faculty have indicated that they have not referenced unlabeled or unapproved uses of drugs or devices.

University of Tennessee Advanced Studies in Pharmacy provides disclosure information from contributing authors, lead presenters, and participating faculty. University of Tennessee Advanced Studies in Pharmacy does not provide disclosure information from authors of abstracts and poster presentations. The reader shall be advised that these contributors may or may not maintain financial relationships with pharmaceutical companies.

     
Home | Contact Us | View Account | Need Help?